Medicare Enrolled
Dr. Moutaz Sunbuli, M.D.
Pulmonary Disease · Chicago Ridge, IL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Sunbuli from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Sunbuli?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Sunbuli
Dr. Moutaz Sunbuli is a pulmonary disease specialist in Chicago Ridge, IL, with 19 years of NPI registration. Based on federal Medicare data, Dr. Sunbuli performed 50,658 Medicare services across 2,048 unique beneficiaries.
Between the years covered by Open Payments, Dr. Sunbuli received a total of $6,301 from 35 pharmaceutical and/or device companies across 330 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pulmonary disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Sunbuli is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 0% volume in IL
$6,301 industry payments
Medicare Practice Summary
Medicare Utilization ↗50,658
Medicare services
Top 0% in IL for pulmonary disease
2,048
Unique beneficiaries
$13
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~2,666 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Therapeutic respiratory procedure, 15 minutes A one-on-one, face-to-face therapeutic procedure designed to improve respiratory function. The session includes monitoring and is billed per 15 minutes. |
41,869 | $9 | $38 |
| Inhalation treatment for airway obstruction or sputum production A treatment involving the inhalation of medication to help clear airway obstructions or reduce sputum production. |
5,841 | $8 | $45 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
561 | $98 | $550 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
457 | $71 | $209 |
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
420 | $180 | $992 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
383 | $97 | $286 |
| Remote patient monitoring management, 20 min/month Management based on results from remote vital sign monitoring for the first 20 minutes per calendar month. |
161 | $40 | $150 |
| Breathing device use evaluation An assessment of how a patient uses a breathing device. The provider reviews the patient's technique and device handling. |
155 | $14 | $52 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
136 | $66 | $238 |
| Remote vital sign monitoring management, each additional 20 minutes This code covers the time spent by a provider managing patient data from remote vital sign monitoring devices. It applies to each additional 20-minute increment beyond the initial monthly service period. |
116 | $33 | $120 |
| Remote patient monitoring device, 30 days Initial setup of devices for remote monitoring of body functions with daily data transmission or alerts. This service covers the first 30 days of the monitoring period. |
105 | $40 | $150 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
60 | $141 | $541 |
| Spirometry test before and after medication A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication. |
51 | $28 | $195 |
| Lung volume test using sensors A test that measures the amount of air in the lungs using sensors. |
51 | $41 | $178 |
| Pulmonary gas exchange test A test to examine how well the lungs exchange gases. |
51 | $41 | $177 |
| Smoking cessation counseling, 4-10 minutes A brief counseling session focused on helping patients quit smoking and tobacco use. The provider spends 4 to 10 minutes discussing strategies and support for cessation. |
49 | $15 | $44 |
| Exercise-induced lung stress test A test performed to evaluate how the lungs function during physical exertion. It helps identify breathing difficulties or lung conditions that occur specifically when exercising. |
43 | $25 | $106 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
38 | $137 | $385 |
| Bronchial irrigation and suction for cell collection This procedure uses an endoscope to flush and suction the lung airways in order to collect cells for testing. |
29 | $104 | $840 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
27 | $108 | $320 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
21 | $109 | $274 |
| Additional 30 minutes of critical care This code represents an additional 30 minutes of critical care services provided beyond the initial critical care time period. |
12 | $91 | $333 |
| Sedation by physician, initial 15 minutes Administration of a drug to induce depression of consciousness by the physician performing a procedure. This code covers the initial 15 minutes of sedation for patients aged 5 years or older. |
11 | $11 | $139 |
| Transitional care management services, moderate complexity Services provided to coordinate care during the transition from an inpatient or other facility setting back to the community. This includes follow-up and management of a health problem of at least moderate complexity. |
11 | $159 | $440 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$6,301
Total received (2018-2024)
Avg $900/year across 7 years
Top 26% in IL for pulmonary disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
35
Companies
330
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,853 (92.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$448 (7.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,192
2023
$1,309
2022
$1,134
2021
$655
2020
$423
2019
$869
2018
$719
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$319
GlaxoSmithKline, LLC.
$198
Inspire Medical Systems, Inc.
$149
Regeneron Healthcare Solutions, Inc.
$82
United Therapeutics Corporation
$65
Insmed, Inc.
$65
Electromed, Inc.
$60
Avadel CNS Pharmaceuticals, LLC
$59
Amgen Inc.
$48
Actelion Pharmaceuticals US, Inc.
$39
Takeda Pharmaceuticals U.S.A., Inc.
$39
GENZYME CORPORATION
$37
Philips North America LLC
$17
INOGEN, INC.
$14
Top 3 companies account for 55.8% of 2024 payments
All-time payments by company (2018-2024) ›
GlaxoSmithKline, LLC.
$1,397
AstraZeneca Pharmaceuticals LP
$1,005
Actelion Pharmaceuticals US, Inc.
$493
JAZZ PHARMACEUTICALS INC.
$485
Boehringer Ingelheim Pharmaceuticals, Inc.
$413
Inspire Medical Systems, Inc.
$302
Electromed, Inc.
$268
GENZYME CORPORATION
$223
Regeneron Healthcare Solutions, Inc.
$200
Mallinckrodt Hospital Products Inc.
$179
Genentech USA, Inc.
$109
Grifols USA, LLC
$104
Amgen Inc.
$95
Avadel CNS Pharmaceuticals, LLC
$95
Merck Sharp & Dohme LLC
$91
Takeda Pharmaceuticals U.S.A., Inc.
$70
Teva Pharmaceuticals USA, Inc.
$70
United Therapeutics Corporation
$65
Insmed, Inc.
$65
Inogen, Inc.
$63
Pulmonx Corporation
$62
Philips Electronics North America Corporation
$61
Sunovion Pharmaceuticals Inc.
$59
Mylan Specialty L.P.
$45
Janssen Pharmaceuticals, Inc
$42
Jazz Pharmaceuticals Inc.
$39
Baxter Healthcare
$39
Merck Sharp & Dohme Corporation
$29
Mallinckrodt Enterprises LLC
$27
Mallinckrodt LLC
$22
Novartis Pharmaceuticals Corporation
$20
Circassia Pharmaceuticals Inc
$20
Philips North America LLC
$17
INOGEN, INC.
$14
Gilead Sciences, Inc.
$14
Top 3 companies account for 45.9% of all-time payments
Associated products mentioned in payments ›
(8874) inCourage · (AK6) Vest Therapy · ACTHAR · AIRSUPRA · ANORO · ANORO ELLIPTA · AirDuo Digihaler · Arikayce · ArmonAir Digihaler · BREZTRI · CHARTIS CATHETER · CINQAIR · DIFICID · DUPIXENT · DreamStat Cpap Pro · Esbriet · FASENRA · GLASSIA · Hillrom - Life 2000 Ventilation System · Hillrom - Vest System Model 105 Home Care · INOGEN ONE G5 OXYGEN CONCENTRATOR - BLUETOOTH · INSPIRE · InogenOne · Inspire Upper Airway Stimulation System · LONHALA MAGNAIR · LUMAKRAS · LUMRYZ · NUCALA · OFEV · OPSUMIT · OPSUMIT MACITENTAN · Prolastin-C Liquid · SMARTVEST · SPIRIVA · SPIRIVA RESPIMAT · STIOLTO · STIOLTO RESPIMAT · SUNOSI · SYMBICORT · TEZSPIRE · TRELEGY ELLIPTA · TUDORZA PRESSAIR · TYVASO · Trilogy 100 · UPTRAVI · XARELTO · XOLAIR · XYREM · XYWAV · Xolair · Xyrem · Yupelri · ZERBAXA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (93%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Pulmonary diseases within 10 mi
250
Per 100K population
4.8
County median income
$81,797
Nearest hospital
ADVOCATE CHRIST HOSPITAL & MEDICAL CENTER
1.6 mi
1.6 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Sunbuli is a mixed practice specialist, with above-average Medicare volume (top 0% in IL), with low-engagement industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Sunbuli experienced with therapeutic respiratory procedure, 15 minutes?
Based on Medicare claims data, Dr. Sunbuli performed 41,869 therapeutic respiratory procedure, 15 minutes services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Sunbuli receive payments from pharmaceutical companies?
Yes. Dr. Sunbuli received a total of $6,301 from 35 companies across 330 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Sunbuli's costs compare to other pulmonary diseases in Chicago Ridge?
Dr. Sunbuli's average Medicare payment per service is $13. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Sunbuli) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Pulmonary Disease
Common procedures, typical costs, and what industry payments mean in pulmonary disease.
Same specialty & city
Pulmonary Diseases in Chicago Ridge
Browse pulmonary diseases in Chicago Ridge ranked by procedure volume and transparency data.
Highest volume
Top Pulmonary Diseases in IL
Pulmonary diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pulmonary Diseases in IL
Which IL pulmonary diseases receive the most from drug and device companies.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Actelion Pharmaceuticals US, Inc. Payments to Doctors
See all physicians who received payments from Actelion Pharmaceuticals US, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology